The global bioinformatics market size garnered US$ 6.66 billion in 2019 and is expected to reach US$ 18.60 billion by 2027, growing at a CAGR of 14% from 2020 to 2027. The report provides a detailed analysis of top investment pockets, changing market trends, major segments, market size & estimations, value chain, and competitive landscape.
Increase in need for integrated data, applications in drug discovery & development, and supportive government initiatives drive the growth of the market. However, scarcity of skilled personnel, saturation in pharmaceutical sector, and availability of common data formats restrain the market growth. On the other hand, data overload, standardization, and requirement for integrated solutions & systems create new pathways in the industry.
The global bioinformatics market is expected to register substantial growth in the near future, owing to rise in need for integrated data, rise in demand for nucleic acid & protein sequencing, owing to reduction in sequencing cost, and increase in applications of proteomics & genomics. In addition, drug discovery & development and initiatives from government & private organizations are expected to boost the market growth during the forecast period. However, lack of skilled personnel, common data formats, and lack of user-friendly tools at cheaper prices are projected to hamper the market growth during the forecast period. Conversely, increase in need for integrated solutions & systems, integration of machine learning & AI in healthcare and software companies investing in the development of bioinformatics solutions are expected to offer remunerative market opportunities to bioinformatics solution developers.
What is Bioinformatics?
Bioinformatics is a combination of biology and information technology, which links biological data with techniques for information storage, distribution, and analysis to support multiple areas of scientific research, including biomedicine. It uses software tools for database creation, data management, data warehousing, data mining, and others. Mining such data leads to scientific discoveries, which is used in the study of genetics & genomes. Several bioinformatics tools are available in the market. They are categorized as protein functional & analysis tools, homology & similarity tools, sequence analysis tools, and miscellaneous tools. The field covers many advanced and specialized areas of life such as structural genomics, functional genomics, DNA microarrays, comparative genomics, and medical information. Hence, these aforementioned factors boost the global bioinformatics market share.
Technology & services segment review
On the basis of technology & services, the bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. The bioinformatics platforms segment was the major revenue contributor in 2019, and is anticipated to continue this trend during the forecast period, owing to increase in platform applications and need for better tools in drug development. Increase in platform application is attributed to surge in need from the life science firm for identification and modification of structures. This, in turn, would help in drug designing process and evaluation of their therapeutic effects. Furthermore, efficiency and safety in drug development and discovery leads to increase in need for better tools in drug development. Thus, is expected to propel the bioinformatics market size in the future.
Application segment review
Depending on application, the bioinformatics market is categorized into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics & drug design, genomics, and others. The transcriptomics segment is projected to exhibit the highest growth during the forecast period, owing to increase in preference in companion diagnostics and personalized medicines. Moreover, novel gene sequencing, continuous discovery of biomarkers, and worldwide acceptance of transcriptomics technology are expected to drive the bioinformatics market growth.
Region segment review
Region wise, the bioinformatics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2019, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to surge in adoption of advanced technology and increase in demand for better bioinformatics tools, which are required in drug discovery and development process. The market in LAMEA is expected to grow at the highest CAGR during the forecast period, owing to advancements in the field of genomics and proteomics, generating massive volume of data, which is to be interpreted and managed. In addition, the bioinformatics sector is still in its infancy stage in the region where research activities are developing gradually. Thus, all these factors together contribute toward growth of the market.
The report analyzes and forecasts the bioinformatics market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2020 to 2027. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global bioinformatics market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the bioinformatics market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of bioinformatics market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Key Market Players
Leading market players analyzed in the research include Accelrys, Inc., Agilent technologies, Inc., Affymetrix, Inc., Non Linear Dynamics, Genevabioinformatics, Life Technologies Corp., Quest Diagnostics, Inc., Bruker Daltonics, Inc., Illumina, and Biomax informatics AG.
Segmentation:
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Section 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Section 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Section 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning/ market share analysis 2018
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in need for integrated data
3.4.1.2. Increase in growth in proteomics & genomics
3.4.1.3. Drug discovery and development
3.4.2. Restraints
3.4.2.1. Lack of skilled personnel
3.4.2.2. Common data formats
3.4.3. Opportunity
3.4.3.1. Increase in need for integrated solutions & systems
3.5. Porter’s five forces analysis
3.6. Key Regulations
3.7. Value chain analysis
3.8. Bioinformatics in the drug development process
3.9. Patent analysis
3.10. Case studies
Section 4: BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Knowledge Management Tools
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Generalized knowledge management tools
4.2.2.1.1. Market size and forecast
4.2.2.2. Specialized knowledge management tools
4.2.2.2.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Bioinformatics Platforms
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Sequence analysis platforms
4.3.2.1.1. Market size and forecast
4.3.2.2. Sequence alignment platforms
4.3.2.2.1. Market size and forecast
4.3.2.3. Sequence manipulation platforms
4.3.2.3.1. Market size and forecast
4.3.2.4. Structural analysis platforms
4.3.2.4.1. Market size and forecast
4.3.2.5. Others
4.3.2.5.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
4.4. Bioinformatics Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Sequencing services
4.4.2.1.1. Market size and forecast
4.4.2.2. Database and management
4.4.2.2.1. Market size and forecast
4.4.2.3. Data Analysis
4.4.2.3.1. Market size and forecast
4.4.2.4. Others
4.4.2.4.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country
Section 5: BIOINFORMATICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Genomics
5.2.1. Metagenomics
5.2.2. Population genomics
5.2.3. Market size and forecast, by region
5.2.4. Market analysis, by country
5.3. Chemoinformatics and Drug Design
5.3.1. Market Size and Forecast, By Region
5.3.2. Market analysis, by country
5.4. Proteomics
5.4.1. Market Size and Forecast, by region
5.4.2. Market analysis, by country
5.5. Transcriptomics
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Metabolomics
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
5.7. Molecular Phylogenetics
5.7.1. Market size and forecast
5.7.2. Market analysis, by country
5.8. Other application market
5.8.1. Pharmacogenomics
5.8.2. Pharmacoproteomics
5.8.2.1. Market size and forecast
5.8.3. Market analysis, by country
Section 6: GLOBAL BIOINFORMATICS MARKET BY SECTOR
6.1. Overview
6.1.1. Market size and forecast, by region
6.2. Medical bioinformatics
6.2.1. Drug development
6.2.2. Molecular medicine
6.2.3. Preventive medicine
6.2.4. Gene therapy
6.2.5. Market size and forecast, by region
6.2.6. Market analysis, by country
6.3. Animal Bioinformatics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Agricultural bioinformatics
6.4.1. Crop yield improvement
6.4.2. Pest resistance
6.4.3. Plant resistance against abiotic stresses
6.4.4. Improve nutritional quality
6.4.5. Market size and forecast by region
6.4.6. Market analysis, by country
6.5. Academics
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
6.6. Others (Microbial genome)
6.6.1. Market size and forecast, by region
6.6.2. Market analysis, by country
Section 7: BIOINFORMATICS MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America bioinformatics market, by country
7.2.2.1. U.S. bioinformatics market, by technology and services
7.2.2.2. U.S. bioinformatics market, by application
7.2.2.3. U.S. bioinformatics market, by sector
7.2.2.4. Canada bioinformatics market, by technology and services
7.2.2.5. Canada bioinformatics market, by Application
7.2.2.6. Canada bioinformatics market, by sector
7.2.2.7. Mexico bioinformatics market, by technology and services
7.2.2.8. Mexico bioinformatics market, by application
7.2.2.9. Mexico bioinformatics market, by sector
7.2.3. North America bioinformatics market, by technology and services
7.2.4. North America bioinformatics market, by Application
7.2.5. North America bioinformatics market, by Sector
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe bioinformatics market, by country
7.3.2.1. Germany bioinformatics market, by technology and services
7.3.2.2. Germany bioinformatics market, by application
7.3.2.3. Germany bioinformatics market, by sector
7.3.2.4. France bioinformatics market, by technology and services
7.3.2.5. France bioinformatics market, by application
7.3.2.6. France bioinformatics market, by sector
7.3.2.7. UK bioinformatics market, by technology and services
7.3.2.8. UK bioinformatics market, by application
7.3.2.9. UK bioinformatics market, by sector
7.3.2.10. Italy bioinformatics market, by technology and services
7.3.2.11. Italy bioinformatics market, by application
7.3.2.12. Italy bioinformatics market, by sector
7.3.2.13. Spain bioinformatics market, by technology and services
7.3.2.14. Spain bioinformatics market, by application
7.3.2.15. Spain bioinformatics market, by sector
7.3.2.16. Rest of Europe bioinformatics market, by technology and services
7.3.2.17. Rest of Europe bioinformatics market, by application
7.3.2.18. Rest of Europe bioinformatics market, by sector
7.3.3. Europe bioinformatics market, by technology and services
7.3.4. Europe bioinformatics market, by application
7.3.5. Europe bioinformatics market, by sector
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific bioinformatics market, by country
7.4.2.1. Japan bioinformatics market, by technology and services
7.4.2.2. Japan bioinformatics market, by Application
7.4.2.3. Japan bioinformatics market, by sector
7.4.2.4. China bioinformatics market, by technology and services
7.4.2.5. China bioinformatics market, by application
7.4.2.6. China bioinformatics market, by sector
7.4.2.7. India bioinformatics market, by technology and services
7.4.2.8. India bioinformatics market, by application
7.4.2.9. India bioinformatics market, by sector
7.4.2.10. Australia bioinformatics market, by technology and services
7.4.2.11. Australia bioinformatics market, by application
7.4.2.12. Australia bioinformatics market, by sector
7.4.2.13. South Korea bioinformatics market, by technology and services
7.4.2.14. South Korea bioinformatics market, by application
7.4.2.15. South Korea bioinformatics market, by sector
7.4.2.16. Taiwan bioinformatics market, by technology and services
7.4.2.17. Taiwan bioinformatics market, by Application
7.4.2.18. Taiwan bioinformatics market, by sector
7.4.2.19. Rest of Asia-Pacific bioinformatics market, by technology and services
7.4.2.20. Rest of Asia-Pacific bioinformatics market, by application
7.4.2.21. Rest of Asia-Pacific bioinformatics market, by sector
7.4.3. Asia-Pacific bioinformatics market, by technology and services
7.4.4. Asia-Pacific bioinformatics market, by application
7.4.5. Asia-Pacific bioinformatics market, by sector
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA bioinformatics market, by country
7.5.2.1. Brazil bioinformatics market, by technology and services
7.5.2.2. Brazil bioinformatics market, by application
7.5.2.3. Brazil bioinformatics market, by sector
7.5.2.4. Saudi Arabia bioinformatics market, by technology and services
7.5.2.5. Saudi Arabia bioinformatics market, by application
7.5.2.6. Saudi Arabia bioinformatics market, by sector
7.5.2.7. South Africa bioinformatics market, by technology and services
7.5.2.8. South Africa bioinformatics market, by application
7.5.2.9. South Africa bioinformatics market, by sector
7.5.2.10. Rest of LAMEA bioinformatics market, by technology and services
7.5.2.11. Rest of LAMEA bioinformatics market, by application
7.5.2.12. Rest of LAMEA bioinformatics market, by sector
7.5.3. LAMEA bioinformatics market, by technology and services
7.5.4. LAMEA bioinformatics market, by application
7.5.5. LAMEA bioinformatics market, by sector
Section 8: COMPANY PROFILES
8.1. AGILENT TECHNOLOGIES, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIOMAX INFORMATICS AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Key strategic moves and developments
8.3. BRUKER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. DASSAULT SYSTEMES
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.5. EUROFINS SCIENTIFIC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Business performance
8.6. GENEVA BIOINFORMATICS (GENEBIO) S.A.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. ILLUMINA, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. PERKINELMER INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. QIAGEN N.V.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. THERMO FISHER SCIENTIFIC, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 02. BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY TYPE, 2018–2026 ($MILLION)
TABLE 03. BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2018–2026 ($MILLION)
TABLE 04. BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY TYPE, 2018–2026 ($MILLION)
TABLE 05. BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY REGION, 2018–2026 ($MILLION)
TABLE 06. BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY TYPE, 2018–2026 ($MILLION)
TABLE 07. BIOINFORMATICS SERVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. GLOBAL BIOINFORMATICS MARKET, BY APPLICATION 2018-2026($MILLION)
TABLE 09. GLOBAL BIOINFORMATICS MARKET FOR GENOMICS, BY REGION 2018-2026 ($MILLION)
TABLE 10. BIOINFORMATICS MARKET FOR CHEMOINFORMATICS AND DRUG DESIGN, BY REGION 2018-2026 ($MILLION)
TABLE 11. BIOINFORMATICS MARKET FOR PROTEOMICS, BY REGION 2013-2020 ($MILLION)
TABLE 12. BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY REGION 2013-2020 ($MILLION)
TABLE 13. BIOINFORMATICS MARKET FOR METABOLOMICS, BY REGION 2013 – 2020 ($MILLION)
TABLE 14. BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY REGION 2013-2020 ($MILLION)
TABLE 15. BIOINFORMATICS MARKET FOR OTHER APPLICATION, BY REGION 2013 – 2020 ($MILLION)
TABLE 16. GLOBAL BIOINFORMATICS MARKET BY SECTOR, 2018-2026($MILLION)
TABLE 17. MEDICAL BIOINFORMATICS SECTOR MARKET, BY REGION 2018-2026 ($MILLION)
TABLE 18. ANIMAL BIOINFORMATICS SECTOR MARKET, BY REGION 2018-2026 ($MILLION)
TABLE 19. AGRICULTURE BIOINFORMATICS SECTOR MARKET, BY REGION 2018-2026 ($MILLION)
TABLE 20. GLOBAL BIOINFORMATICS ACADEMICS MARKET, BY REGION 2018-2026 ($MILLION)
TABLE 21. BIOINFORMATICS MARKET FOR OTHERS SECTORS, BY REGION 2018-2026 ($MILLION)
TABLE 22. BIOINFORMATICS MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 23. NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. U.S. BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 25. U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 26. U.S. BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 27. CANADA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 28. CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 29. CANADA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 30. MEXICO BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 31. MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 33. NORTH AMERICA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 34. NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35. NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 36. EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 37. GERMANY BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 38. GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39. GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 40. FRANCE BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 41. FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 42. FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 43. UK BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 44. UK BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 45. UK BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 46. ITALY BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 47. ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 48. ITALY BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 49. SPAIN BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 50. SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 51. SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 52. REST OF EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 53. REST OF EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. REST OF EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 55. EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 56. EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 57. EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 58. ASIA-PACIFIC BIOINFORMATICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 59. JAPAN BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 60. JAPAN BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 61. JAPAN BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 62. CHINA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 63. CHINA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 64. CHINA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 65. INDIA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 66. INDIA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 67. INDIA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 68. AUSTRALIA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 69. AUSTRALIA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 70. AUSTRALIA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 71. SOUTH KOREA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 72. SOUTH KOREA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73. SOUTH KOREA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 74. TAIWAN BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 75. TAIWAN BIOINFORMATICS MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 76. TAIWAN BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 78. REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 80. ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 81. ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 82. ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 83. LAMEA BIOINFORMATICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 84. BRAZIL BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 85. BRAZIL BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 86. BRAZIL BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 87. SAUDI ARABIA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 88. SAUDI ARABIA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 89. SAUDI ARABIA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 90. SOUTH AFRICA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 91. SOUTH AFRICA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 92. SOUTH AFRICA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 93. REST OF LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 94. REST OF LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 95. REST OF LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 96. LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2018–2026 ($MILLION)
TABLE 97. LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 98. LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2018–2026 ($MILLION)
TABLE 99. AGILENT: COMPANY SNAPSHOT
TABLE 100. AGILENT: OPERATING SEGMENTS
TABLE 101. AGILENT: PRODUCT PORTFOLIO
TABLE 102. BIOMAX INFORMATICS AG.: COMPANY SNAPSHOT
TABLE 103. BIOMAX INFORMATICS AG.: OPERATING SEGMENTS
TABLE 104. BIOMAX INFORMATICS AG.: PRODUCT PORTFOLIO
TABLE 105. BRUKER CORPORATION: COMPANY SNAPSHOT
TABLE 106. BRUKER CORPORATION: OPERATING SEGMENTS
TABLE 107. BRUKER CORPORATION: PRODUCT PORTFOLIO
TABLE 108. DASSAULT SYSTEMES: COMPANY SNAPSHOT
TABLE 109. DASSAULT SYSTEMES: OPERATING SEGMENTS
TABLE 110. DASSAULT SYSTEMES: PRODUCT PORTFOLIO
TABLE 111. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 112. EUROFINS SCIENTIFIC.: PRODUCT PORTFOLIO
TABLE 113. GENEVA BIOINFORMATICS (GENEBIO) SA: COMPANY SNAPSHOT
TABLE 114. GENEVA BIOINFORMATICS (GENEBIO) SA: OPERATING SEGMENTS
TABLE 115. GENEVA BIOINFORMATICS (GENEBIO) SA: PRODUCT PORTFOLIO
TABLE 116. ILLUMINA: COMPANY SNAPSHOT
TABLE 117. ILLUMINA: OPERATING SEGMENTS
TABLE 118. ILLUMINA: PRODUCT PORTFOLIO
TABLE 119. PERKINELMER: COMPANY SNAPSHOT
TABLE 120. PERKINELMER: OPERATING SEGMENTS
TABLE 121. PERKINELMER: PRODUCT PORTFOLIO
TABLE 122. QIAGEN: COMPANY SNAPSHOT
TABLE 123. QIAGEN: PRODUCT PORTFOLIO
TABLE 124. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 125. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 126. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. TOP INVESTMENT POCKETS, 2018
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04. HIGH BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE THREAT OF SUBSTITUTION
FIGURE 06. MODERATE THREAT OF NEW ENTRANT
FIGURE 07. HIIGH COMPETITIVE RIVALRY
FIGURE 08. VALUE CHAIN ANALYSIS
FIGURE 09. PATENT REGISTERED, BY YEAR, 2016-2018
FIGURE 10. PATENT REGISTERED, BY COUNTRY, 2016-2018
FIGURE 11. GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, 2018–2026 ($MILLION)
FIGURE 12. SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, 2018–2026 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 14. SEQUENCE ANALYSIS PLATFORM MARKET, 2018–2026 ($MILLION)
FIGURE 15. SEQUENCE ALIGNMENT PLATFORM MARKET, 2018–2026 ($MILLION)
FIGURE 16. SEQUENCE MANIPULATION PLATFORMS MARKET, 2018–2026 ($MILLION)
FIGURE 17. STRUCTURAL ANALYSIS PLATFORMS MARKET, 2018–2026 ($MILLION)
FIGURE 18. OTHER BIOINFORMATICS PLATFORM MARKET, 2018–2026 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 20. SEQUENCING SERVICES MARKET, 2018–2026 ($MILLION)
FIGURE 21. DATABASE AND MANAGEMENT BIOINFORMATICS MARKET, 2018–2026 ($MILLION)
FIGURE 22. DATA ANALYSIS MARKET, 2018–2026 ($MILLION)
FIGURE 23. OTHER BIOINFORMATICS SERVICES MARKET, 2018–2026 ($MILLION)
FIGURE 24. COMPARATIVE ANALYSIS OF BIOINFORMATICS MARKET FOR SECTOR, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR GENOMICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR CHEMOINFORMATICS AND DRUG DESIGN, BY COUNTRY, 2018 & 2026 (%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR PROTEOMICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR METABOLOMICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET OTHER APPLICATION, BY COUNTRY, 2018 & 2026 (%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR MEDICAL BIOINFORMATICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR ANIMAL BIOINFORMATICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 34. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR AGRICULTURE BIOINFORMATICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 35. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR ACADEMICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 36. COMPARATIVE SHARE ANALYSIS OF BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 37. AGILENT: NET SALES, 2016–2018 ($MILLION)
FIGURE 38. AGILENT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. BRUKER CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 40. BRUKER CORPORATION: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 41. BRUKER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 42. DASSAULT SYSTEMES: NET SALES, 2016–2018 ($MILLION)
FIGURE 43. DASSAULT SYSTEMES: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 44. DASSAULT SYSTEMES: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 45. EUROFINS SCIENTIFIC.: REVENUE, 2016–2018 ($MILLION)
FIGURE 46. EUROFINS SCIENTIFIC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 47. ILLUMINA: NET SALES, 2016–2018 ($MILLION)
FIGURE 48. ILLUMINA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 49. ILLUMINA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 50. PERKINELMER: NET SALES, 2016–2018 ($MILLION)
FIGURE 51. PERKINELMER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 52. PERKINELMER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 53. QIAGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 54. QIAGEN: REVENUE SHARE BY PRODUCT, 2018 (%)
FIGURE 55. QIAGEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 56. THERMO FISHER SCIENTIFIC: REVENUE, 2016–2018 ($MILLION)
FIGURE 57. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 58. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY REGION, 2018 (%)
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers